$AMED
AMEDISYS INC

2014 Q2 Form 10-Q Financial Statement

#000119312514286327 Filed on July 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $305.0M $316.0M
YoY Change -3.48% -14.66%
Cost Of Revenue $172.5M $176.1M
YoY Change -2.02% -13.09%
Gross Profit $132.5M $138.2M
YoY Change -4.12% -15.42%
Gross Profit Margin 43.44% 43.73%
Selling, General & Admin $112.2M $122.3M
YoY Change -8.26% -10.92%
% of Gross Profit 84.68% 88.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.700M $9.600M
YoY Change -19.79% -3.03%
% of Gross Profit 5.81% 6.95%
Operating Expenses $119.9M $131.6M
YoY Change -8.89% -10.48%
Operating Profit $12.56M $3.793M
YoY Change 231.16% -75.3%
Interest Expense $1.352M $730.0K
YoY Change 85.21% -63.54%
% of Operating Profit 10.76% 19.25%
Other Income/Expense, Net -$208.0K $111.0K
YoY Change -287.39% -106.51%
Pretax Income $12.35M $3.300M
YoY Change 274.33% -75.83%
Income Tax $4.743M $1.300M
% Of Pretax Income 38.4% 39.39%
Net Earnings $7.600M $1.800M
YoY Change 322.22% -77.22%
Net Earnings / Revenue 2.49% 0.57%
Basic Earnings Per Share $0.24 $0.06
Diluted Earnings Per Share $0.23 $0.06
COMMON SHARES
Basic Shares Outstanding 32.25M shares 31.16M shares
Diluted Shares Outstanding 32.59M shares 31.49M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.20M $30.10M
YoY Change -62.79% -19.09%
Cash & Equivalents $11.23M $30.12M
Short-Term Investments
Other Short-Term Assets $36.80M $27.00M
YoY Change 36.3% 8.87%
Inventory
Prepaid Expenses
Receivables $110.9M $124.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $158.9M $181.8M
YoY Change -12.6% -23.06%
LONG-TERM ASSETS
Property, Plant & Equipment $148.3M $156.9M
YoY Change -5.48% 7.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $163.3M $109.2M
YoY Change 49.54% 362.59%
Total Long-Term Assets $551.4M $518.5M
YoY Change 6.35% -16.64%
TOTAL ASSETS
Total Short-Term Assets $158.9M $181.8M
Total Long-Term Assets $551.4M $518.5M
Total Assets $710.3M $700.3M
YoY Change 1.43% -18.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.90M $21.70M
YoY Change -12.9% -11.16%
Accrued Expenses $169.6M $130.4M
YoY Change 30.06% 109.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.30M $35.80M
YoY Change -65.64% -41.02%
Total Short-Term Liabilities $200.7M $191.0M
YoY Change 5.08% -22.04%
LONG-TERM LIABILITIES
Long-Term Debt $132.0M $39.00M
YoY Change 238.46% -42.39%
Other Long-Term Liabilities $6.500M $5.200M
YoY Change 25.0% 21.67%
Total Long-Term Liabilities $132.0M $39.00M
YoY Change 238.46% -45.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $200.7M $191.0M
Total Long-Term Liabilities $132.0M $39.00M
Total Liabilities $338.4M $236.7M
YoY Change 42.97% -25.33%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $371.9M $463.6M
YoY Change
Total Liabilities & Shareholders Equity $710.3M $700.3M
YoY Change 1.43% -18.41%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $7.600M $1.800M
YoY Change 322.22% -77.22%
Depreciation, Depletion And Amortization $7.700M $9.600M
YoY Change -19.79% -3.03%
Cash From Operating Activities -$89.20M $33.60M
YoY Change -365.48% 58.49%
INVESTING ACTIVITIES
Capital Expenditures -$3.600M -$9.500M
YoY Change -62.11% -5.0%
Acquisitions
YoY Change
Other Investing Activities -$900.0K $2.200M
YoY Change -140.91% -127.85%
Cash From Investing Activities -$4.500M -$7.400M
YoY Change -39.19% -58.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 102.0M -3.100M
YoY Change -3390.32% -58.11%
NET CHANGE
Cash From Operating Activities -89.20M 33.60M
Cash From Investing Activities -4.500M -7.400M
Cash From Financing Activities 102.0M -3.100M
Net Change In Cash 8.300M 23.10M
YoY Change -64.07% -677.5%
FREE CASH FLOW
Cash From Operating Activities -$89.20M $33.60M
Capital Expenditures -$3.600M -$9.500M
Free Cash Flow -$85.60M $43.10M
YoY Change -298.61% 38.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7627000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
113000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2688000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3017000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
283000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
700000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9740000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2215000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1200000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
414000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5958000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95471000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9068000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
67000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9392000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1324000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98785000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6078000
us-gaap Interest Paid
InterestPaid
2006000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2959000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
74000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-708000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
100000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2878000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30118000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
627000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1695000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27904000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15573000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
400000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35684000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14545000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8722000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9210000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
126000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19679000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15634000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
6227000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
2495000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
200800000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25500000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1135000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
537000
us-gaap Pension Expense
PensionExpense
3048000
us-gaap Pension Expense
PensionExpense
4363000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
-1549000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
167000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
2082000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
2233000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24215000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
0
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
93000
amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
-115000000
amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
357000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2967000
CY2014Q2 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5 pure
CY2014Q2 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.2 pure
CY2014Q2 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5 pure
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP. In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> condensed</font><font style="font-family:Times New Roman;font-size:10pt;"> consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p>
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">and Comparability </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications have been made to prior period's financial statements in order to conform to the current period's presentation</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:6pt; margin-bottom:0pt'>&#160;</p>
CY2014Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33 States
CY2014Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
CY2013Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.84 pure
CY2013Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
11900000
CY2014Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
15000000
CY2014Q2 us-gaap Cost Method Investments
CostMethodInvestments
5000000
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1 pure
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
3000000
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.69 pure
CY2013 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
6600000
CY2014Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2013Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1500000
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2014Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
144300000
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
217000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12000 shares
CY2014Q2 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
343000 shares
CY2013Q2 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
317000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
381000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
649000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32251000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31160000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32058000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30900000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32594000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31489000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32058000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31298000 shares
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
132000000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-300000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-400000
CY2014Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
100000
CY2014Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
8900000
CY2013Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-100000
CY2013Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-300000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-600000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
19500000
CY2014Q1 amed Number Of Care Centers Included In Divestiture Plan
NumberOfCareCentersIncludedInDivestiturePlan
43 Agencies
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
46900000
CY2014Q2 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.5 pure
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33000000
CY2014Q2 amed Total Leverage Ratio
TotalLeverageRatio
2.7 pure
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
144300000
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
amed Medicare Revenue
MedicareRevenue
4000000
amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
115000000
amed Final Payment Of Us Department Of Justice Settlement
FinalPaymentOfUsDepartmentOfJusticeSettlement
35000000
amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
116500000
CY2014Q1 amed Relators Attorneys Fees For Us Department Of Justice Settlement
RelatorsAttorneysFeesForUsDepartmentOfJusticeSettlement
3900000
amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
234300000
CY2014Q2 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
108000000
CY2013Q2 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
117700000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments

Files In Submission

Name View Source Status
0001193125-14-286327-index-headers.html Edgar Link pending
0001193125-14-286327-index.html Edgar Link pending
0001193125-14-286327.txt Edgar Link pending
0001193125-14-286327-xbrl.zip Edgar Link pending
amed-20140630.xml Edgar Link completed
amed-20140630.xsd Edgar Link pending
amed-20140630_cal.xml Edgar Link unprocessable
amed-20140630_def.xml Edgar Link unprocessable
amed-20140630_lab.xml Edgar Link unprocessable
amed-20140630_pre.xml Edgar Link unprocessable
d761980d10q.htm Edgar Link pending
d761980dex1010.htm Edgar Link pending
d761980dex1012.htm Edgar Link pending
d761980dex104.htm Edgar Link pending
d761980dex105.htm Edgar Link pending
d761980dex106.htm Edgar Link pending
d761980dex107.htm Edgar Link pending
d761980dex108.htm Edgar Link pending
d761980dex109.htm Edgar Link pending
d761980dex311.htm Edgar Link pending
d761980dex312.htm Edgar Link pending
d761980dex321.htm Edgar Link pending
d761980dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g761980fslogonew.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending